Unveiling NRlncRNAs as prognostic biomarkers and therapeutic targets for head‐and‐neck squamous cell carcinoma through machine learning
Environmental Toxicology · 2024
DOI: 10.1002/tox.24108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Jiao Shao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Head and Neck Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Medical health science and technology plan projects in Wenzhou (Y20210102), Foundation of Wenzhou Medical University (202102242015).
Abstract (Originalsprache)
Head‐and‐neck squamous cell carcinoma (HNSCC) patients often exhibit insensitivity to immunotherapy, leading to treatment failure. Identifying potential biomarkers that can predict prognosis and improve the efficacy of treatment is crucial. In this study, we aimed to identify necroptosis‐related long noncoding RNAs (NRlncRNAs) as potential therapeutic targets to improve the prognosis of HNSCC patients. By exploring the Genotype‐Tissue Expression Project (GTEx) and the Cancer Genome Atlas (TCGA) databases, we identified NRlncRNAs and developed a risk model comprising 17 NRlncRNAs to predict the prognosis of HNSCC patients and to classify patients into two clusters based on their expression levels. We conducted various analyses, such as the Kaplan–Meier analysis, GSEA and IC50 prediction, to evaluate the differences in sensitivity to immunotherapy between the two clusters. Our findings suggest that NRlncRNAs have potential as therapeutic targets for improving the prognosis of HNSCC patients, and that individualized treatment approaches based on NRlncRNA expression levels can improve the sensitivity of immunotherapy and overall treatment outcomes. This study highlights new perspectives within clinical cancer informatics and provides insight into potential therapeutic strategies for HNSCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
- The First Affiliated Hospital of Harbin Medical University, School of Stomatology, Harbin Medical University, Harbin, China.
ORCID-Profile: Jiao Shao
Förderung
- Medical health science and technology plan projects in Wenzhou (Y20210102)
- Foundation of Wenzhou Medical University (202102242015)
Zitieren
APA
Shao, J., Xiong, B., Lei, D., & Chen, X. (2024). Unveiling NRlncRNAs as prognostic biomarkers and therapeutic targets for head‐and‐neck squamous cell carcinoma through machine learning. Environmental Toxicology. https://doi.org/10.1002/tox.24108
Vancouver
Shao J, Xiong B, Lei D, Chen X. Unveiling NRlncRNAs as prognostic biomarkers and therapeutic targets for head‐and‐neck squamous cell carcinoma through machine learning. Environmental Toxicology. 2024. doi:10.1002/tox.24108
BibTeX
@article{Shao2024,
author = {Shao, Jiao and Xiong, Bo and Lei, Deru and Chen, Xiaojian},
title = {Unveiling NRlncRNAs as prognostic biomarkers and therapeutic targets for head‐and‐neck squamous cell carcinoma through machine learning},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.24108}
}
EUVIMED